Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/NYMOX PHARMACEUTICAL CORP/ 20-F

SEC Filing · 20-F

NYMOX PHARMACEUTICAL CORP

SEC Filing

Filed May 2, 2023Accepted May 2, 2023, 4:29 AM EDTCIK 1018735Accession 0001640334-23-000736
View company →Permanent SEC source ↗
Share

Company context

Current securities

NYMXFOTC · EQUITY · Current
Historical securities (1)
NYMXNASDAQ · EQUITY · Historical · closed Jul 6, 2023

Recent company filings

  1. 20-F/A filingSep 29, 2026
  2. 20-F/A filingSep 16, 2026
  3. 20-F filingSep 14, 2026
  4. 6-K filingAug 31, 2026
  5. 6-K filingAug 7, 2026

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗